The Latest: BioNTech says it plans 2 billion vaccine doses

Germany’s BioNTech, which developed the first COVID-19 vaccination on the market with American partner Pfizer, says it expects to produce 2 billion doses in 2021 with ramped-up manufacturing.
Company CEO and co-founder Ugur Sahin says with three manufacturing sites in the United States and three in Europe operating or coming online soon, it expects to approximately double the number of doses committed for this fiscal year.
The company said in a presentation Monday to the annual J.P. Morgan